Promising Opportunities for Cardiovascular Monitoring Equipment in Europe

Technologically advanced, cost-effective cardiovascular monitoring systems are increasingly in demand in Europe. The need for sophisticated, yet user-friendly equipment at affordable rates will offer market participants considerable growth opportunities in this sector.

These are the latest findings of Frost and Sullivan (Palo Alto, CA, USA), an international consulting firm. Cardiovascular diseases are one of the leading causes of premature death; furthermore, statistics have revealed that one in five teenagers suffers from the early signs of heart disease. Additionally, lifestyle changes and an aging population underpin the increasing incidence of cardiovascular-related illnesses. These trends are contributing to an increased need for diagnostic cardiovascular monitoring equipment, which are finding wider application in hospitals and cardiac rehabilitation centers to enable effective diagnosis and therapy.

However, while ECG is a well-established procedure, there have not been significant technologic breakthroughs in recent years and the market continues to persist with old technologies. This situation has been exacerbated by the lack of funds for the research and development of innovative technologies. Moreover, a persistent focus on treatment, rather than monitoring modalities, is threatening to impede market momentum. Market expansion is expected to be sustained by technological enhancements that promote greater user friendliness and improve networking and communication capabilities, while supporting cost efficiencies. In the future, growth opportunities will exist for companies that will be able to form strategic alliances to meet evolving end-user demands, despite intense competition among themselves.

"Larger participants have always had the upper hand because of their reputation and the superior brand awareness that they have been able to create. This is threatening the survival of smaller competitors,” said Frost & Sullivan research analyst Gideon V. Praveen Kumar.

Frost & Sullivan has found that the cardiovascular monitoring equipment market in Europe earned revenues of US$350 million in 2007 and estimates this to reach $491 million in 2014.

Related Links:
Frost and Sullivan